Espère Healthcare Ltd
Working with research based partners in Europe and North America, Espère Healthcare Ltd has pioneered the development of a range of innovative solutions for the treatment of various skin and wound care related conditions.
Our products can be accessed via a number of specific websites which provide you with all the information necessary to make an informed choice regarding their use. We believe that it is important that prescribers, parents and patients have access to products that have been trialled, tested and found to be effective, so all our products start life in clinical settings.
Operating Address
Registered Address
Shefford House, 15 High Street, Shefford, SG17 5DD
Company Registration Number: 05032968
VAT Registration Number: GB829924290
For over 20 years Espère Healthcare Ltd has been improving the lives of everybody that we connect with through our products, our people, our attitude, our service, and our activities.
Our products are registered Medical Devices, hand chosen for their ability to treat skin conditions that continue to affect patients, despite medical intervention. They come from both small and global manufacturers but have one thing in common – they perform as described!
A company grows by the quality of its people and reliability of its service. We have built a reputation for evidence–led, impartial advice and prompt delivery to clients ranging from the NHS National Woundcare Strategy to a small child with eczema in Orkney.
The next stage in our evolutionary journey reflects our key position within the BAP Medical Group of Companies. As BAP Medical UK Limited we aim to maintain the care and attention that we give to every aspect of our interactions with our UK customers whilst operating within the security of a globally active parent company.
You can find our products on several specific websites that provide all the information you need to make an informed decision. We believe it’s important for prescribers, parents, and patients to have access to products that have been thoroughly tested and proven effective. That's why all our products are first used in clinical settings before becoming available to you.
Certificate No. 367342021
REGISTERED ADDRESS
Shefford House, 15 High Street, Shefford, SG17 5DD
Company Registration Number: 05032968
VAT Registration Number: GB829924290
Carbon Reduction Plan - Espère Healthcare Ltd
Publication date: April 2024
Commitment to achieving Net Zero
Espere Healthcare Ltd is committed to achieving Net Zero emissions by 2050.
Baseline Emissions Footprint
Baseline emissions are a record of the greenhouse gases that have been produced in the past and were produced prior to the introduction of any strategies to reduce emissions. Baseline emissions are the reference point against which emissions reduction can be measured.
Baseline Year 2023
Additional Details relating to the Baseline Emissions calculations.
This is the first full year of emissions reporting following the expansion of the business’ Commercial unit and subsequent market expansion.
| Emissions | TOTAL (tCO2e) |
| Scope 1 | 0.2 |
| Scope 2 | 1.1 |
|
Scope 3 (Included Sources) |
14.1 of which
|
| Total Emissions | 15.41 – equivalent to 1.71 per employee |
Current Emissions Reporting Not yet available
| Emissions | TOTAL (tCO2e) |
| Scope 1 | xx |
| Scope 2 | xx |
| Scope 3 | xx |
| Total Emissons | xx |
Emissions reduction targets
With a growing, evolving small business it is difficult to commit to an overall reduction in emissions as additional staff which may be employed in the next 3-5 years will have the effect of increasing the overall company emissions in the short term. In order to make sense of our progress to achieving Net Zero, we have adopted the following carbon reduction targets, based upon a CO2 figure per employee.
We project that carbon emissions will decrease over the next five years from the current 1.71 tonnes per employee to 1.2 tCO2e per employee by 2030. This is a reduction of 30%.
Carbon Reduction Projects
Completed Carbon Reduction Initiatives
The following environmental management measures and projects have been completed or implemented since before the 2023 baseline so they are outside the scope of the plan but reflect the desire of the company to do all it can to progress the road to carbon neutrality.
-
Centralising the packaging and despatch facility allowed for a general reduction in business travel to support warehouse activities.
-
We have already replaced all of our lighting in the office and warehouse to LED
-
We have recently transferred to a green energy supplier for gas and electricity
-
All computer screens are low emission panels
-
Our Sales team run Hybrid vehicles and replace car travel with train and tube wherever possible in inner cities
-
40% of meetings are now conducted remotely, reducing travel costs
-
Open windows have replaced air conditioning in the Summer Months
-
All received packaging is recycled in our despatch department.
The carbon emission reduction achieved by these schemes equate to approximately 3 tCO2e, prior to the calculation of the 2023 baseline. There is obviously an ongoing benefit and the measures will be in effect when performing the contract.
In the future we hope to implement further measures such as:
- Full electrification of the Sales vehicles. (The MD has already transitioned from Diesel to pure Electric, but range hampers the progression of the sales team from hybrids)
- Investigating the transition of electricity to solar and / or night charging battery technology. (Scope 2 is only 7% of our CO2 usage so gains will be minimal)
- Adding a controllable “Hive” type system to the heating to make the building more economical in the winter months. Again, a heat pump heating solution would be considered when the current domestic, sized boiler nears end of life but Scope 1 costs are only 0.2 tCO2e so there is little to gain in terms of carbon reduction as the boiler tends to only be used for 3-4 months of the year.
Declaration and Sign Off
This Carbon Reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard1 and uses the appropriate Government emission conversion factors for greenhouse gas company reporting2.
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard3.
This Carbon Reduction Plan has been reviewed and signed off by the board of directors.
The above statement was approved and signed on behalf of the supplier by the Managing Director of Espère Healthcare Ltd.
Chris Steeples
Managing Director
8th April 2024